Cory Berkland The University of Kansas Verified email at ku.edu. ... L Wang, CJ Berkland, MS Detamore. Annals of biomedical engineering 38, 2167-2182, 2010. 136: 2010:Shara Thati, 1 Christopher Kuehl, 1 Brittany Hartwell, 2 Joshua Sestak, 1 Teruna Siahaan, 1 Laird Forrest, 1 and Cory Berkland 1, 3, * ... Davies NM, Berkland CJ, Forrest ML. Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer. International journal of pharmaceutics. 2010; 392 (1 ...01/02/2010 ... ... Cory Berkland, Ph.D., who, with George Laurence, invented the company's NanoCluster technology in his laboratory at the University of Kansas ...Berkland C, King M, Cox A, Kim K, Pack DW. Precise control of PLG microsphere size provides enhanced control of drug release rate . Journal of Controlled Release . 2002 Jul 18;82(1):137-147. doi: 10.1016/S0168-3659(02)00136-0The aim of this project was to develop a gene replacement therapy for treating Charcot-Marie-Tooth disease type 4C to rescue the phenotype of the Sh3tc2-/- mouse model. We generated a lentiviral vector LV-Mpz.SH3TC2.myc to drive expression of the human SH3TC2 cDNA under the control of the Mpz promoter specifically in myelinating Schwann cells.C. Berkland, K. Kim, and D.W. Pack (2004) Controlling double-walled microcapsule shell thickness offers modulated piroxicam release Journal of Biomedical Materials Research 70A(4):576-584 C. Berkland, K. Kim, and D.W. Pack (2004) Uniform double-walled polymer microspheres of controllable shell thickness Journal of Controlled Release, 96(1):101-111Dennis4, and Cory Berkland1,4,* 1Department of Pharmaceutical Chemistry, University of Kansas, Lawrence KS 66047 2Department of Pharmaceutics and Industrial Pharmacy, ... 864-1454, [email protected]. NIH Public Access Author Manuscript Mol Pharm. Author manuscript; available in PMC 2014 October 23.K-State News Kansas State University 128 Dole Hall 1525 Mid-Campus Dr North Manhattan, KS 66506. 785-532-2535 [email protected] LAB TEAM. Our group is made up of extraordinary people that are well versed in the synthesis and characterization of polymers and colloids, validating and quantifying conjugation reactions, and formulating these materials for in vivo applications. They have developed novel approaches for controlling the physicochemical properties of ...Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.2.1. Determination of Cytotoxicity of Doxorubicin (Dox), Idarubicin (Ida), and Curcumin (Cur) on Leukemic Cell Viability by MTT Assay. A cell viability curve demonstrated Dox (Figure 1 A) and IDa (Figure 1 B) exhibited the highest cytotoxicity for EoL-1 cells, followed by U937, KG-1, and KG-1a cells.The cytotoxicity of all the treatments was …Fixed-dose combinations are gaining popularity because they provide convenience while enhancing patient compliance. Literature examples suggest that many fixed-dose combinations are being rationalized and investigated for their potential utility in therapy. This article provides an introspection int …Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors . Pharmaceutical Research . 2003 Jul 1;20(7):1055-1062. doi: 10.1023/A:1024466407849 Cory Berkland. Chemical & Petroleum Engineering, 1530 West 15th Street, University of Kansas, Lawrence, Kansas 66045-7609. Department of Pharmaceutical Chemistry, 2095 Constant Ave, University of Kansas, Lawrence, Kansas 66045-7609. Search for more papers by this authorGage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells ...30/05/2018 ... 2012 Cory Berkland. 2011 Molly Stevens. 2010 Krish Roy. 2009 Justin Hanes. 2008 Samir Mitragotri. 2007 David Putnam. 2006 Stefaan De Smedt. 2005 ...Dr. Vincent H. Key is a Orthopedist in Kansas City, KS. Find Dr. Key's phone number, address, insurance information, hospital affiliations and more.Jian Qian 1 , Cory Berkland 2 Affiliations 1 Department of ... KS 66045, United States. Electronic address: [email protected]. PMID: 31655253 PMCID: PMC6820273 DOI: 10.1016/j.isci.2019.10.022 Abstract The design and synthesis of metal chelators with extraordinary metal affinities is a basic and challenging scientific problem of both fundamental ...Corporate Faith - 2023 Business Speakers Series - Cory Berkland. Mon, Aug 14, 6:00 PM. Undivided Experience Center • Chesterfield, MO. Free. Save Corporate Faith - 2023 Business Speakers Series - Cory Berkland to your collection.Dr. Cory Berkland - University of Kansas (Host: Professor Patti) Happy Hour in Bryan 5th Floor - 3 to 4pm. Note: There will not be a receiption after the seminar. Zoom Session. Christopher Thuet is inviting you to a scheduled Zoom meeting. Topic: Dr. Cory Berkland - SeminarDiaz is a scholar in the IMSD program, and she is mentored by Cory Berkland, the Solon E. Summerfield Distinguished Professor of Pharmaceutical Chemistry and of chemical & petroleum engineering. Mariah Dray, of Dillingham, Alaska, is a student at Haskell Indian Nations University studying environmental science. Dray is mentored by Bill Welton ...Cory's current address is 1300 Coconino Rd, Ames, IA. We know that one company — Mmc Photography, LLC — is registered at this address. We know that Julie M Anderson, Hyungjoo Choi, and 374 other persons also lived at this address, perhaps within a different time frame.Records show that Cory also lived at 802 Dickinson Ave, Ames, IA 50014.How it works: Cory Berkland, Ph.D., professor at the University of Kansas, is a serial entrepreneur, co-founding Orbis Biosciences, Savara Pharmaceuticals and Orion Biosciences, as well as co-developing several technologies with industry partners. In late 2012, IAMI invested in novel polymer technology discovered by Dr. Berkland with the intent ...Jim Berkland. James O. Berkland (July 31, 1930 – July 22, 2016) was an American geologist [1] who controversially claimed to be able to predict earthquakes, including the 1989 Loma Prieta earthquake and 1994 Northridge Earthquake [2] and who popularized the idea that some people are earthquake sensitive. He was profiled in a popular 2006 book ...Cory Berkland. Solon E. Summerfield Distinguished Professor ; PHARMACEUTICAL CHEMISTRY; Contact Info. 785-864-1455. Multidisciplinary Research Building, Room 320D 2030 Becker Drive Lawrence, KS 66047 Learned Hall, Room 4160C 1530 West 15th Street Lawrence, KS 66045 Personal Links.Great news for Engineering Distinguished Professor Cory Berkland... Quote. University of Kansas · @UnivOfKansas. ·. Mar 30, 2017. A KU pharmaceutical ...Autoantigen-specific immunotherapy using peptides offers a more targeted approach to treat autoimmune diseases, but the limited in vivo stability and uptake of peptides impedes clinical implementation. We previously showed that multivalent delivery of peptides as soluble antigen arrays (SAgAs) efficiently protects against spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse model.Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character Taryn R. Bagby1, Shuang Cai1, Shaofeng Duan1, Qiuhong Yang1, Sharadvi Thati1, Cory Berkland1, Daniel J. Aires2, and M. Laird Forrest1,* 1 Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS 2 Division of Dermatology, Dept. of Internal Medicine ...Ph.D. Candidate under Dr. Cory Berkland and Dr. Laird Forrest in the Department of Pharmaceutical Chemistry, University of Kansas. Specialized in Peptide-based Delivery Strategies to Enhance ...Cory Berkland holds the Solon E. Summerfield Distinguished Professorship in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS ...Cory Berkland. [email protected]; Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047===Search for more papers by this authorHyaluronic acid (HA) is a naturally occurring biodegradable polymer with a variety of applications in medicine, including scaffolding for tissue engineering, dermatological fillers and viscosupplementation for osteoarthritis treatment. HA is available in most connective tissues in body fluids such as synovial fluid and the vitreous humor of …Contact Info [email protected] 785-864-1455 Multidisciplinary Research Building, Room 320E Research — In recent history, through the merger of engineering and biological sciences, biotechnology has pressed toward improving methods for regenerating tissues, developing biosensors, and effectively delivering therapeutic agents.Vaccine-like Controlled-Release Delivery of an Immunomodulating Peptide to Treat Experimental Autoimmune Encephalomyelitis Barlas Büyüktimkin1, Qun Wang2, Paul Kiptoo1, John M. Stewart1, Cory Berkland1,2, and Teruna J. Siahaan1,* 1Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KSChuda Chittasupho, Sheng-Xue Xie, Abdulgader Baoum, Tatyana Yakovleva, Teruna J. Siahaan, Cory J. Berkland. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. European Journal of Pharmaceutical Sciences 2009, 37 (2) , 141-150.Nabil Alhakamy • Cory Berkland • Jin Chen • Dana Brantley-Sieders • Nikki Cheng Received: 4 December 2014/Accepted: 24 February 2015/Published online: 6 March 2015 Springer Science+Business Media New York 2015 Abstract Luminal A and B breast cancers are the most prevalent forms of breast cancer diagnosed in women.Nov 11, 2020 · Chad Groer, 1 Ti Zhang, 1 Ruolin Lu, 2 Shuang Cai, 1 Derek Mull, 1 Aric Huang, 2 Melanie Forrest, 1 Cory Berkland, 2, 3 Daniel Aires, 1, 4 and Marcus Laird Forrest 1, 2, * Chad Groer 1 HylaPharm LLC, Lawrence, Kansas Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile .Cory Berkland; Published in issue: February 2015. p346-361. Full-Text HTML; PDF Rapid Communication. Microneedles for Drug Delivery via the Gastrointestinal Tract. Giovanni Traverso, Carl M. Schoellhammer, Avi Schroeder,... Daniel G. Anderson, Daniel Blankschtein, Robert Langer;Cory Berkland. [email protected]; Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047===Search for more papers by this authorIntroduction. Stem cell-based therapies hold great promise in regenerative medicine for the treatment of a variety of diseases in which the body's ability to repair tissue is hampered or irreversibly compromised [].To name a few, myocardial infarction, osteoarthritis or bone fractures, and nonunions represent such medical conditions.Course Search. Search class sections | Online courses. Library SearchAbdulgader Baoum, 1 Sheng-Xue Xie, 1 Amir Fakhari, 2 and Cory Berkland 1, 3, 4 Abdulgader Baoum 1 Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USA3. The student ban is cruel. Expelling students in the middle of a pandemic serves no useful purpose. It does not increase their safety or the safety of U.S. nationals.Cory Berkland, CEO [email protected]. Release Summary. Phase Ia/b will assess the safety of BBI-001 and test the ability of BBI-001 to prevent iron uptake from food. Contacts.Cory Berkland, Solon E. Summerfield Distinguished Professor; Stevin Gehrke, Fred Kurata Memorial Professor; Trung Van Nguyen, professor; Mark Shiflett, Foundation Distinguished Professor; Bala Subramaniam, Dan F. Servey Distinguished Professor; Civil, environmental & architectural engineering. David Darwin, Deane E. Ackers Distinguished ProfessorChuda Chittasupho, Teruna J Siahaan, Charlotte M Vines, Cory Berkland. Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics. Therapeutic Delivery 2011, 2 (7) , 873-889.Settimio Pacelli, a, 1 Sayantani Basu, a, 1 Jonathan Whitlow, a Aparna R. Chakravarti, a Francisca Acosta, a Arushi Varshney, b Saman Modaresi, a Cory Berkland, a, c and Arghya Paul a Settimio Pacelli11/02/2023 ... Curt Berkland passed away on February 11, 2023 in Emmetsburg, Iowa. Funeral Home Services for Curt are being provided by Martin-Mattice ...The most common forms of proteosomes used for vaccine applications are nanoparticles composed of the outer membrane proteins (OMPs) of Neisseria meningitidis. OMPs have been used successfully in a marketed meningococcal vaccine since 1981 and are considered non-toxic and well-tolerated [160], [161].Nabil A Alhakamy, Ph.D. candidate (Co-advised with Dr. Cory Berkland) Lorena Antunez, Ph.D. candidate (Co-advised with Dr. Cory Berkland) Aishik Chakraborty, Ph.D. student Saba Ghazvini, Ph.D. student Rachel Hathaway, M.S. Under-Graduate Students. Kimberley Cole Erica Hui Monica Ketchum ...Cory Berkland. Chemical & Petroleum Engineering, 1530 West 15th Street, University of Kansas, Lawrence, Kansas 66045-7609. Department of Pharmaceutical Chemistry, 2095 Constant Ave, University of Kansas, Lawrence, Kansas 66045-7609. Search for more papers by this authorCorresponding Author. Cory Berkland. [email protected]; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66047 USA. E-mail: [email protected]; [email protected] Search for more papers by this authorEurope PMC is an archive of life sciences journal literature.pH-responsive microgels are crosslinked polymer colloid particles that swell when the pH approaches the pK a of the polybase or polyacid chains. Poly(vinylamine) (PVAM) has the highest primary amine content of all amine-containing polymers.Despite much effort the preparation of colloidally stable PVAM microgels is still elusive.Cory Berkland View For the in vitro release experiment, 50 µl of UM-3003 adsorbed alhydrogel formulation was mixed with 500 µl of adjuvant-free human plasma in a closed glass vial at 37 °C and ...Cory Berkland. 2004, Biomaterials. Improved control of surface micro-and nano-structure may lead to enhanced performance of degradable biomedical devices such as surgical dressings, vascular grafts, tissue engineering scaffolds, sutures, and structures for guided tissue regeneration. An electrohydrodynamic method called flow-limited field ...Alhakamy, Nabil A; Nigatu, Adane S; Berkland, Cory J et al. (2013) Noncovalently associated cell-penetrating peptides for gene delivery applications. Ther Deliv 4:741-57 Alhakamy, Nabil A; Berkland, Cory J (2013) Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes. Mol Pharm 10:1940-8Photo: Bryce Stottlemire, a doctoral student in bioengineering, displays one of the face shields designed and fabricated in the labs of Mei He, assistant professor of chemical & petroleum engineering, and Cory Berkland, Solon E. Summerfield Distinguished Professor of Pharmaceutical Chemistry.Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.1. Introduction. Fixed dose combinations (FDCs) are defined as a combination of two or more active ingredients within a single form of pharmaceutical administration [Citation 1 – Citation 6].They have been shown to appreciably reduce the risk of medication non-adherence, which is particularly important in patients with chronic diseases [Citation …Chairperson: Dr. Cory Berkland Date approved: November 8, 2016 . iii Abstract Multiple Sclerosis (MS) is an autoimmune disease characterized by the breakdown of immune tolerance towards autoantigen in the myelin sheath surrounding the neurons. CurrentChittasupho C, Xie S-X, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. European Journal of Pharmaceutical Sciences. 2009; …Cory Berkland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).Cory Berkland The University of Kansas Verified email at ku.edu. Limin Wang rice university Verified email at rice.edu. ... MM Bailey, SR Kline, MD Anderson, JL Staymates, C Berkland. Journal of applied polymer science 126 (4), 1218-1227, 2012. 10: 2012: Fluorinated polymers and associated methods. C Berkland, M Bailey. US Patent App. 12/ ...Gehrke, Professor Cory Berkland, Professor Kevin Leonard, and Professor David Volkin. Beside my adviser, I have been a teaching assistant of Professors Gehrke and Berkland during my studies at KU that not only gave me an opportunity to observe and learn their teaching style, but gave me a chance to explore my passion for teaching and mentoring.Singkome Tima; Siriporn Okonogi; Chadarat Ampasavate; Cory Berkland; Songyot Anuchapreeda: 1-Jan-2009: HPLC determination of mangostin and its application to storage stability study: Pathom Jujun; Krisana Pootakham; Yanee Pongpaibul; Prasit Tharavichitkul; Chadarat Ampasavate: 16-Feb-2016INTRODUCTION. Autoimmune diseases such as multiple sclerosis (MS) are typified by a breakdown of healthy immune regulation and subsequent misrecognition of self for non-self. 1-2 The autoimmune breakdown in MS is largely propagated by autoreactive T and/or B cell clonal expansion and attack against myelin sheath autoantigens, leading to demyelination and neurodegeneration. 3-6 Activation ...Biography —. Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry.Amir Fakhari. Quang Phan. Cory Berkland. Hyaluronic acid (HA) is a naturally occurring biodegradable polymer with a variety of applications in medicine. The use of HA as a filler or scaffold for ...Jim Berkland. James O. Berkland (July 31, 1930 – July 22, 2016) was an American geologist [1] who controversially claimed to be able to predict earthquakes, including the 1989 Loma Prieta earthquake and 1994 Northridge Earthquake [2] and who popularized the idea that some people are earthquake sensitive. He was profiled in a popular 2006 book ...Berkland C, Kim K, Pack DW. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J Control Release 2001; 73: 59-74. ... Cory J Berkland. Department of Chemical and Petroleum Engineering, University of Kansas, USA. Department of Pharmaceutical Chemistry, University of Kansas, USA ...A method of forming particles comprises accelerating a stream comprising a liquid; and vibrating the stream, to form particles. The particle may have a diameter that is smaller than the diameter of the nozzle used to form the stream, allowing for the formation of micro- and nano-sized particle.Cory Berkland. [email protected]; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047Search for more papers by this authorBERKLAND LAB TEAM. Our group is made up of extraordinary people that are well versed in the synthesis and characterization of polymers and colloids, validating and quantifying conjugation reactions, and formulating these materials for in vivo applications. They have developed novel approaches for controlling the physicochemical properties of polymers and particles to improve therapeutic ...Chittasupho C, Sestak J, Shannon L, Siahaan TJ, Vines CM, Berkland C. Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro. Mol Pharm. 2013;11(1):367-73. doi: 10.1021/mp4003909. [Europe PMC free article]Gage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. 2020 Mar;39(11):2275-2289. doi: 10.1038/s41388-019-1141-7. Noncovalently associated cell-penetrating peptides for gene delivery applications. 2013 Jun;4 (6):741-57. doi: 10.4155/tde.13.44. Nabil A Alhakamy Adane S Nigatu Cory J Berkland Joshua D Ramsey. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA. 23738670.Brad Spitz, Nathan Dormer & Cory Berkland are part of Orbis Biosciences leadership, Maria Stecklein Flynn is the CEO.The company's lead candidate, BBI-001, is an iron chelator for the treatment of hereditary hemochromatosis. Bond joins the St. Louis ecosystem after licensing technology originally developed at the University of Kansas. Bond was founded by St. Louisan and serial entrepreneur Cory Berkland, PhD."We are pleased to begin this first-in-human clinical trial of our lead non-absorbed oral therapy and thankful for the seasoned development team that contributed to this significant milestone," said Dr. Cory Berkland, Bond's CEO, Chairman of the Board and Co-founder.Co-Founder & Chief Executive Officer at Context Therapeutics. Mr. Lehr is the Co-founder and CEO of Context Therapeutics. In addition, Mr. Lehr is a member of the Scientific Advisory Board of Integral Molecula r, an antibody discovery company. Previously, Martin was part of the founding team at Osage University Partners, a venture capital fund focused on academic spinouts from leading research ...2014: Cory Berkland, professor, Department of Pharmaceutical Chemistry and Department of Chemical and Petroleum Engineering 2013: Lisa Stehno-Bittel, professor, Department of Physical Therapy and Rehabilitation Science.Recently, lymphocyte function-associated antigen-1 (LFA-1), a primary cell adhesion molecule, has also been investigated for targeting nanoparticles to human leukemic cell line ( 30, 32 ). Lima et al. reported that certain leukemic cells expressed 5-fold more LFA-1 than normal leukocytes ( 32 ). Since LFA-1 is expressed only on leukocytes, it ...J. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122.Cory Berkland Jian QIAN Original Assignee The University Of Kansas Priority date (The priorit, Berkland, Cory J. Publisher. Nature Publishing Group. Type. Article. Article Version. Scholarly/re, Complexes were formed by addition of appropriate volumes of pDNA and TAT with or without CaC, Cory Berkland View For the in vitro release experiment, 50 µl of UM-3003 , Cory Berkland, CEO [email protected] Release Summary Bond's clinical lead, BBI-001, is designed t, Cory Berkland Ph.D: Co-Founder, Chief Scientific Officer & Board Member: Bowman Fishback: Co-Found, Cory Berkland; Content type: Research Article Published: 06 , Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, B, Veisi, Masoumeh , Johnson, Stephen , Peltier, Karen, Search 4 grants from Maria Flynn Search 22 grants from Cor, Berkland C, Kim K, Pack DW. PLG microsphere size contro, Cory Berkland. Chemical & Petroleum Engineering, 1530 West 15th St, Joel Berkland is a Sales & Marketing Manager at W, Cory Berkland, Ph.D. Abstract Basic principles have e, Cory Berkland, PhD Solon E. Summerfield Distinguished Profes, Sep 1, 2022 · Abstract: Particles for delivery of active , Aillon Kristin L, El-Gendy Nashwa, Dennis Connor, Norenb, May 5, 2019 · Hartwell BL; Pickens CJ; Leon M; Berkl.